Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Absolutely, MMs are dumping shares they don't own, 44.4 million shares Shorted today
<<<<<<< More dumping today, 48,067,000 shares >>>>>>>
Less than 12,000 shares were sold today by the actual owners of those shares.
FINRA Reg SHO Daily Short Report
Date ... Symbol .. Short vol ... Total vol
20240424 | BIEL | 44480000 | 56127000
Retail Traders can not enter a 5 digit to the right of the decimal point order.
However, five digit executed orders do turn up frequently by way of MMs filling an order placed at the Ask Price at a lower price.
Today's five digit fills were entered at the Ask of .0002 and filled at .00014 & .00015 .
Yesterday's closing order for 100,000 shares, along with several others, was entered at a .0002 SP but filled at .00015 .
What a load of nonsense
<<<<< inept management team continues to unload shares on an unsuspecting public >>>>>
Per the 2023 Financials:
KW only owns 37 million shares.
RS owns Zero shares.
KN only owns 100 million shares.
BIEL only has 295 million shares available in their Authorized Shares and they do not sell shares directly into the Market.
"STOP PRETENDING" is what I say every time a statistic from phony 'Sales Track' flows out of your libelous cakehole
Actually 279 million shares were Sells, 6 million Buys, but 191 million shares were Shorted
Date ..... Symbol .. Short vol ... Total vol
20240423 | BIEL | 191987615 | 285678650
It's hard to crow about a "300 million share sell-off" when the MMs sold 191 million shares that they did not own.
Somewhere between 88 and 94 million shares were sold at 1 today by shareholders who actually owned the shares that they sold.
The spike in 2021 is no mystery
BIEL signed the KT Tape deal in 2020. Q4 of 2020 saw 9500 lbs of the KT Wave shipped to KT.
Q2 of 2021 saw 2 shipments to KT totaling 19,000 lbs of the Wave.
BIEL lived up to their end of the contract, suppling all of the Wave devices that KT ordered.
KT failed to aggressively market the Wave. They priced it $5 higher than ActiPatch, $34.95, and reduced the hours of use from 720 to 250. Existing ActiPatch customers said, 'No Thanks'. KT chose to stay in their comfort zone with the athlete/weekend warrior market when the chronic pain market was many times larger.
The Assisi Loop is the animal version of the Endonovo Sofpulse
They use the same 27.12 MHz signal as the ActiPatch but there are several differences.
Assisi/Sofpulse uses 2 of the 2032 3 volt batteries where the ActiPatch uses one.
Assisi/Sofpulse is said to have an 8 day continuous use life span while ActiPatch has a 30 day continuous use life.
Assisi/Sofpulse is made to deliver therapy in sessions of 15-30 minutes with 2 hour gaps between sessions while the ActiPatch delivers a constant, lower powered therapy.
The pulse rate is all so different between the devices.
Further confirmation of efficacy by 2 Universities & 1 Hospital in Rome
Current Evidence Using Pulsed Electromagnetic Fields in Osteoarthritis
Published: 28 March 2024
(1) Background: Osteoarthritis (OA) significantly impacts patients’ quality of life and negatively affects public healthcare costs. The aim of this systematic review is to identify the effectiveness of pulsed electromagnetic fields (PEMFs) in OA treatment across different anatomical districts, determining pain reduction and overall improvement in the patient’s quality of life. (3) Results: PEMF therapy demonstrated positive outcomes across various anatomical districts, primarily in knee osteoarthritis. Pain reduction, assessed through VAS and WOMAC scores, showed significant improvement (60% decrease in VAS, 42% improvement in WOMAC). The treatment duration varied (15 to 90 days), with diverse PEMF devices used. Secondary outcomes included improvements in quality of life, reduced medication usage, and enhanced physical function.
3.2. Type of PEMF Device
These studies investigated the utilization of both presently available PEMF devices on the market and outdated, no longer used equipment. The variety of PEMF devices employed in these studies introduced an additional layer of complexity to the analysis. [Table 2]. Devices such as those from the Bioelectronics Corporation (BioElectronics Corporation- Metropolitan Court Fredrick, MD, USA), Magcell Arthro (Physiomed Elektromedizin-Hutweide, Schnaittach, Germany), and XT-2000 B by the Better Health Corporation (Abbotsford, Victoria, Australia), each characterized by unique specifications like the frequency and intensity of the magnetic field, highlight the technological variability within PEMF therapy. For instance, the Bioelectronics Corporation’s device has a carrier frequency of 27.12 MHz and emits 1000 pulses per second.
4.4. Outcomes and Result Heterogeneity
The consistent focus on pain reduction as a primary outcome, measured using visual analog scales or disease-specific scales, indicates positive trends in PEMFs’ analgesic effects. Diverse secondary outcomes, including quality of life assessments, changes in analgesic and NSAID intake, and improvements in physical function, reflect the multifaceted impact of PEMF therapy on osteoarthritis.
https://www.mdpi.com/2077-0383/13/7/1959
"STOP PRETENDING" says the guy who quotes statistics from the nonexistent Sales Track,
and has to have a disclaimer on all posts to remind people that he deals in "Opinion Only", no pesky facts to worry about.
"Everything I say and write is my opinion and my opinion only."
Ya botched quoting a 13 word sentence
"Anyone with half a brain can see that this was a planned effort."
<<<<<<< So what was the plan? >>>>>>>
Anyone with half a brain has figured it out.
LOL, It was a dump of 23 million shares 1 minute before the Close
All day long the Trades were at .0002, .00025, and .0003, Zero 1s on the Bid and Zero 1s Traded.
At 3:58:51 someone takes out the 1.3 million shares on the 2 Bid.
At 3:59:04, 22 million shares are dumped into the .0001 Bid which has 448 million shares available and the Market closes 56 seconds later.
Anyone with half a brain can see that this was a planned effort.
There is at least one step BIEL has advised shareholders of
<<<<< I want to know what concrete steps the company is taking to take advantage of the change in law >>>>>
2/15/2024 Chairman Update
"The Company also did a proof-of-concept production run of its newly designed RecoveryRx product that is 50% more powerful and has a larger antenna thereby increasing the size of the surgical incision that can be treated. The plan is to test market these devices in the near future."
A 50% increase in power means more pain relief, and faster pain relief. This further reduces the amount of pain relief drugs a surgical patient requires.
2023 Financials
KW foregoes all salary for years ending December 31, 2023 / 2022
IBEX LLC agreed to forgo all interest from 2020 through 2023
Keith Nalepka still owns 100 million BIEL Shares
Dr Staelin supports BIEL with $500k in new loans for 2023
BIEL still investing in R&D $272K
Revenue up from 2022
General/Administrative costs down by $80k compared to 2022
Sales/Marketing cost lowered by $120k compared to 2022
Basic deduction, any substantial sales in Q2, 3 or 4 of 2023 would have been announced by BIEL
Subjects for possible news in Update:
* Further news on the redesigned ActiPatch
* Further news on the new RecoveryRx with a 50% power increase
* Further news on the major distributor talks, final approval
* Further news on the $14 million breach of contract lawsuit against Mundipharma
* Further news on the US direct to consumer sales with "Money Back Guaranty"
* Further news on the Veterinarian market/ Vagus nerve stimulation
* News in areas not previously disclosed
Financials have usually been released after the Market closes
IMO, the numbers from 2023 will not be the thing to focus on. Hopefully an Update will be released shortly after the Financials with information on progress made in 2024.
Regarding yourself that question has been answered, Revenge
<<<<<<<< "Why do you even bother, spending so much time on this?" >>>>>>>>
A former BIEL employee, 'Terminated for Cause', becomes obsessed with destroying his former employer.
Yes, who in their right mind would want to enter the pet market
86 million US households have pets
$136 billion spent on pets in 2023 in US
$235 billion spent world wide on pets
Must be spending too much time around Art
I never said that MMs Shorting was "illegal", but you know that. It is most definitely Shorting and if they did not borrow shares, which is the case most of the time, it is Naked Shorting. MMs use the 'Making a Market' exemption when they Naked Short, they say they had to sell shares that they did not own and had not borrowed in order to maintain Liquidity. The problem is their use of this exemption is rarely questioned so its use is abused for the sake of increasing profits.
All trades currently have the Trade day + 2 business days for the shares to be delivered to the buyer. That rule changes on May 28th to Trade day + 1 business day. MMs have up to 13 days before they suffer any serious consequences from not delivering the shares of their Naked Short Sales.
<<<<< If the MM's didn't try so hard to make a market here, this stock would barely trade at all >>>>>> If no one wants to Sell at the 2 Bid and no one wants to Buy at the 3 Ask that is fine with me, there are shares available at 3, no need to have an MM step in and Sell 35 million shares at 2 as happened on Wednesday, if there are zero trades on a day the SP stays the same, it would seem the MM is the only one not wanting that outcome
You should take your complaint up with FINRA and their "Daily Short Sale Volume Files"
<<<<<< The REGSHO report shows a failure to cover by the MM's >>>>>> and what do they need to cover, a Short Sale
Anyone who Sells shares that they do not own and have not borrowed is Naked Shorting. It does not matter if the duration is 1 hour or 1 year. When the MMs sold 35 million shares yesterday, that they did not own, it was Naked Shorting. MMs can use the Liquidity/ 'Making a Market' excuse for their Shorting but it is still Shorting and it can affect the actions of other investors especially when 85% of the day's trading volume is Short Selling, like yesterday.
MMs make money off of their trading fees and also from their Buy/Sell SP spread. If their computers see an opportunity to make a profit from the SP spread they will jump on it and it is easy for them as they set the Bid/Ask prices.
https://www.finra.org/finra-data/browse-catalog/short-sale-volume-data/daily-short-sale-volume-files
Forgot to mention one very important statistic
Per the FINRA Reg SHO Short Report 4/10/2024 had 35.9 million shares in Shorting.
Date .... Symbol .. Short vol .. Total vol
20240410 | BIEL | 35926101 || 42148500
The Whelans and Dr Staelin owning most of the convertible notes is exactly why I am optimistic about a BIEL Turnaround.
The only way they get their loans repaid is with a profitable BIEL and a rising SP.
There is no market for converted shares with BIEL trading in the triple zeros.
Speaking of SofPulse, they joined BIEL on 'Pink Limited' status last week
<<<<<<< Hope he doesn't wait for the SofPulse trial to finish and publish them together. >>>>>>>
ENDV, the current owner of SofPulse, purchased the SofPulse patents, already FDA Cleared, 6 years ago for $4.5 million . Neither of their own research projects, Immunotronics and Cytotronics, have ever been FDA Cleared.
With a current Market Cap of $1.065 million the ENDV CEO is trying to spin off SofPulse into its own company. They are looking for an analyst that will value the new company at $50-100 million.
ENDV has been trying to purchase a concrete company for several years. That is correct, a medical device company was trying to buy a concrete company. Big surprise, that 'deal' fell through.
ENDV's SP is currently at .0032, this after a 1 for 1,000 Reverse Split 4 years ago. If you had one million shares of ENDV before the RS you now have one thousand shares. To compare ENDV to BIEL, which has no RS, you can add 3 zeros (to the right of the decimal point) back into their current SP, which equals .0000032 .
To the 'Usual Suspects' that claim BIEL is a scam, Allan Collier CEO of ENDV would say, Hold my beer and I will show you what a real scam looks like.
You're one of the handful of desperate Bashers here trying to convince shareholders to sell their shares
Been predicting the end of BIEL at every downturn for the last 12 years, always wrong.
28,113 posts and nothing to show for it.
Notice the handful of very small trades at .0001 to desperately try to hold the price down
Over 24 million shares traded today and only 32k were at .0001 .
Over 400 million shares on the Bid at .0001 today and no one wants to sell.
Just sayin.
LOL, excited by a 32k share trade at 1 worth $3
>>>>>>> this may be it <<<<<<<
"During the first second quarter of 2018, the Company entered into a convertible note agreement with
James Eason, receiving financing of $135,000, with an interest rate of 8% per annum and convertible
at a rate of $.0003 per share. This loan and related interest was converted into 629,856,000 shares of
common stock in July 2020" - From the EOY 2020 Financials
In Q2 2018 BIEL's SP ranged between .001 and .005 .
"The conversion prices on the convertible notes payable have generally been 50% or less of the pink
sheet closing price of the common stock on the date the notes or advances are issued to reflect the
restricted nature of the stock into which the notes could be converted and the Board of Directors’
belief that the closing stock price is not reflective of the fair market value of the common stock due
to the price volatility, and lack of an active market for trading shares resulting in limited trading
volume of share transactions. The Board of Directors is active in negotiating conversion prices for
each issuance and takes into consideration all information in establishing the issuance date fair market
value"
LOL, 6 million Buys to 762k Sells
Go peddle your BS elsewhere.
This website does have a 2024 copyright
" Wayan Srl copyright © 2024 | P. IVA: 02747970909 0.4195 "
https://www.fogliettoillustrativo.net/listino_prodotti/601E/pharmatech-srl?p=1
You have been corrected on this false statement before, yet you keep repeating it
<<<<< 50% discounted priced stock upon their note/loan maturities, when all other stockholders have to pay full price for their shares >>>>>
Your BFF JimmyZ, a BIEL shareholder, got his $135k loan repaid on 7/27/2020 with 629 million, 50% discounted shares. this is documented in BIEL's Financials.
Simpsonly made a post confirming his convertible loan to BIEL and stated anyone who wanted to do the same should give AW a call.
The interest, fees, and terms on any loan are determined by the risk involved. Loaning money to a Pink Sheet company is considered high risk. Pink Sheets need to offer a large reward for taking that risk to attract lenders. Looking at the Financials will show that many of BIEL's lenders are not family members.
Thanks Hawk, that is quite the list of RecoveryRx/ActiPatch products
It appears that BIEL has some new irons in the fire.
"Pharmatech has an outstanding experience in the design, construction and validation of any size or type of project in the Pharmaceutical, Biotechnology and Healthcare fields."
"We offer a complete range of services for any type of Pharma facility, covering the following activities: Consultancy (GMP audit/GAMP analysis, Project URS preparation, Assistance to Site Selection, Site Master Planning, Feasibility Study, Conceptual Design, Process Simulation – Construction Management) Engineering & Construction (Basic Design, Detailed Engineering, Project Management, Project Control, Procurement, Construction Management) Handover (Commissioning, Qualification/Validation, Start-up & training)."
Summary of the product's characteristics
Product Name: recoveryrx post-op kit l 12cm
Manufacturer: pharmatech srl
Product Category: Sanitary Instruments
Product Type: Medical Device
Product Class: 2
AIC code: 924752583
This product has no Aifa notes
Source: https://www.fogliettoillustrativo.net/bugiardino/recoveryrx-kit-post-op-l-12cm-924752583
RECOVERYRX POST-OP KIT L 12CM
Category: Healthcare Instruments (Other), Healthcare Instruments
Type: Medical Device Manufactured by: pharmatech srl
Source: https://www.fogliettoillustrativo.net/listino_prodotti/601E/pharmatech-srl?p=1
RECOVERYRX POST-OP KIT S 8CM
Category: Healthcare Instruments (Other), Healthcare Instruments
Type: Medical Device Manufactured by: pharmatech srl
Source: https://www.fogliettoillustrativo.net/listino_prodotti/601E/pharmatech-srl?p=1
RECOVERYRX ACUTE PAIN KIT
Category: Healthcare Instruments (Other), Healthcare Instruments
Type: Medical Device Manufactured by: pharmatech srl
Source: https://www.fogliettoillustrativo.net/listino_prodotti/601E/pharmatech-srl?p=1
RECOVERYRX BACK KIT
Category: Healthcare Instruments (Other), Healthcare Instruments
Type: Medical Device Manufactured by: pharmatech srl
Source: https://www.fogliettoillustrativo.net/listino_prodotti/601E/pharmatech-srl?p=1
RECOVERYRX KNEE KIT
Category: Healthcare Instruments (Other), Healthcare Instruments
Type: Medical Device Manufactured by: pharmatech srl
Source: https://www.fogliettoillustrativo.net/listino_prodotti/601E/pharmatech-srl?p=1
ALLAY MENSTRUAL PAIN KIT
Category: Healthcare Instruments (Other), Healthcare Instruments
Type: Medical Device Manufactured by: pharmatech srl
Source: https://www.fogliettoillustrativo.net/listino_prodotti/601E/pharmatech-srl?p=1
SMART INSOLE BEAD KIT 1PCS
Category: Healthcare Instruments (Other), Healthcare Instruments
Type: Medical Device Manufactured by: pharmatech srl
Source: https://www.fogliettoillustrativo.net/listino_prodotti/601E/pharmatech-srl?p=1
BIEL's latest CE Mark covers both ActiPatch and RecoveryRx for OTC Sales.
The board's 'Liar-in-Chief' spreading another Load of Manure
This pitiful soul was terminated by BIEL and has spent the last 12 years trying to destroy the company as revenge.
There is a scam artist at work here but it is not BIEL.
The scammer is ddls who stops at nothing, including quoting a nonexistent company, 'Sales Track', to achieve his goal.
Scam companies do not hold 5 FDA Clearances for treating medical conditions.
The FDA says that BIEL's products are effective at reducing pain.
A glaring problem with your KW Bash
<<<<<< since nobody proofreads Whelan's work >>>>>>
KW did not prepare the 2019, 2020, 2021, 2022 EOY financial reports, Brian Flood did. KW signed a statement saying:
"Based on my knowledge, the financial statements, and other financial information included or
incorporated by reference in this disclosure statement, fairly present in all material respects the financial
condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this
disclosure statement."
B. The following financial statements were prepared by (name of individual):
Name: Brian Flood
Title: Consultant
Relationship to Issuer: Consultant
Accountant or Auditor
Name: Brian Flood
Firm: Consult Your CFO
Address 1: 1680 Nickerson Way
Address 2: Arnold, MD 21012
Phone: 443-838-6352
Email: floodbp@gmail.com
Good Grief, No one with a functioning brain believes that there is currently a market for billions of new BIEL shares
KW, PW and RS have a zero chance of getting their loans paid back unless they pull off a major company turnaround.
With millions of dollars at stake the Whelans and Dr Staelin are doing everything possible to breath new life into BIEL.
A Profitable BIEL benefits both lenders and shareholders.
Sales-Track shows that the poster is a habitual liar willing to say anything to inflict damage on BIEL
BIEL fired ddls, with cause, 14 years ago and he has been trying to destroy the company ever since.
Every year same story, "BIEL is doomed", "BK coming any day now", same BS repeated over and over, always wrong.
96 percent efficacy is very rare in a study, nice to see Dr Sree Koneru consulting with BIEL again
https://onlinelibrary.wiley.com/doi/10.1002/vms3.1408
Holding pattern until EOY statement and company Update
3/31 is a Sunday so financials due 4/1 . Update could come before or after financials.
Enjoy.
Wrong again, 1.1 million shares bought at 3 today out of a 1.7 million share total Buy volume
<<<<<<<<< those .0002's became BUYS >>>>>>>>>>
Sells had a whopping 202k shares, 142k of those shares were Sells at 2 . Only 60k shares sold at 1 .
Forgot to mention only 60k shares actually sold at .0001
Buys over Sells 8 to 1 .
LOL, not a good look when your #1 cheerleader is the admitted liar, ddls
But I am confident it will be considered "Fun".